Search hospitals
>
Virginia
>
Fairfax
Inova Schar Cancer Institute
Claim this profile
Fairfax, Virginia 22031
Global Leader in Breast Cancer
Global Leader in Pancreatic Cancer
Conducts research for Lung Cancer
Conducts research for Melanoma
Conducts research for Parkinson's disease
159 reported clinical trials
27 medical researchers
Summary
Inova Schar Cancer Institute is a medical facility located in Fairfax, Virginia. This center is recognized for care of Breast Cancer, Pancreatic Cancer, Lung Cancer, Melanoma, Parkinson's disease and other specialties. Inova Schar Cancer Institute is involved with conducting 159 clinical trials across 189 conditions. There are 27 research doctors associated with this hospital, such as Timothy L. Cannon, Adam Cohen, MD, Janakiraman Subramanian, and David P. Lee, MD.
Area of expertise
Breast Cancer
Inova Schar Cancer Institute has run 40 trials for Breast Cancer. Some of their research focus areas include:
Pancreatic Cancer
Inova Schar Cancer Institute has run 28 trials for Pancreatic Cancer. Some of their research focus areas include:
Top PIs
Timothy L. Cannon
Inova Schar Cancer Institute
4 years of reported clinical research
Adam Cohen, MD
Inova Schar Cancer Institute
2 years of reported clinical research
Janakiraman Subramanian
Saint Luke's Hospital of Kansas City
6 years of reported clinical research
David P. Lee, MD
Stanford Hospital and Clinics
7 years of reported clinical research
Clinical Trials running at Inova Schar Cancer Institute
Breast Cancer
Pancreatic Cancer
Lung Cancer
Skin Cancer
Ovarian Cancer
Cancer
Esophageal cancer
Laryngeal Cancer
Bladder Cancer
Prostate Cancer
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting
2 awards
Phase 3
3 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting
2 awards
Phase 3
3 criteria
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting
2 awards
Phase 3
3 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Inova Schar Cancer Institute?
Inova Schar Cancer Institute is a medical facility located in Fairfax, Virginia. This center is recognized for care of Breast Cancer, Pancreatic Cancer, Lung Cancer, Melanoma, Parkinson's disease and other specialties. Inova Schar Cancer Institute is involved with conducting 159 clinical trials across 189 conditions. There are 27 research doctors associated with this hospital, such as Timothy L. Cannon, Adam Cohen, MD, Janakiraman Subramanian, and David P. Lee, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.